These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9366624)

  • 1. Can we measure prior postmenopausal estrogen/progestin use? The Postmenopausal Estrogen/Progestin Interventions Trial. The PEPI Investigators.
    Greendale GA; James MK; Espeland MA; Barrett-Connor E
    Am J Epidemiol; 1997 Nov; 146(9):763-70. PubMed ID: 9366624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
    Barnabei VM; Phillips TM; Hsia J
    J Womens Health Gend Based Med; 1999 Nov; 8(9):1167-72. PubMed ID: 10595329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopausal hormone replacement therapy and risk of ovarian cancer.
    Lacey JV; Mink PJ; Lubin JH; Sherman ME; Troisi R; Hartge P; Schatzkin A; Schairer C
    JAMA; 2002 Jul; 288(3):334-41. PubMed ID: 12117398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
    Nevitt MC; Felson DT; Williams EN; Grady D
    Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hormone replacement therapy on self-reported cognitive symptoms: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Reboussin BA; Greendale GA; Espeland MA
    Climacteric; 1998 Sep; 1(3):172-9. PubMed ID: 11907941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.
    JAMA; 1996 Nov; 276(17):1389-96. PubMed ID: 8892713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen plus progestin and risk of venous thrombosis.
    Cushman M; Kuller LH; Prentice R; Rodabough RJ; Psaty BM; Stafford RS; Sidney S; Rosendaal FR;
    JAMA; 2004 Oct; 292(13):1573-80. PubMed ID: 15467059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
    Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
    JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
    Palacios S; Currie H; Mikkola TS; Dragon E
    Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy and physical function change among older women in the Women's Health Initiative: a randomized controlled trial.
    Michael YL; Gold R; Manson JE; Keast EM; Cochrane BB; Woods NF; Brzyski RG; McNeeley SG; Wallace RB
    Menopause; 2010 Mar; 17(2):295-302. PubMed ID: 19858764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative.
    Hsia J; Criqui MH; Rodabough RJ; Langer RD; Resnick HE; Phillips LS; Allison M; Bonds DE; Masaki K; Caralis P; Kotchen JM;
    Circulation; 2004 Feb; 109(5):620-6. PubMed ID: 14769684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen plus progestin and colorectal cancer in postmenopausal women.
    Chlebowski RT; Wactawski-Wende J; Ritenbaugh C; Hubbell FA; Ascensao J; Rodabough RJ; Rosenberg CA; Taylor VM; Harris R; Chen C; Adams-Campbell LL; White E;
    N Engl J Med; 2004 Mar; 350(10):991-1004. PubMed ID: 14999111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal hormone use following a 3-year randomized clinical trial.
    Barrett-Connor E; Espeland MA; Greendale GA; Trabal J; Johnson S; Legault C; Kritz-Silverstein D; Einhorn P
    J Womens Health Gend Based Med; 2000; 9(6):633-43. PubMed ID: 10957752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestins affect mechanism of estrogen-induced C-reactive protein stimulation.
    Reuben DB; Palla SL; Hu P; Reboussin BA; Crandall C; Herrington DM; Barrett-Connor E; Greendale GA
    Am J Med; 2006 Feb; 119(2):167.e1-8. PubMed ID: 16443423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
    Cravioto MD; Durand-Carbajal M; Jiménez-Santana L; Lara-Reyes P; Seuc AH; Sánchez-Guerrero J
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1654-63. PubMed ID: 22127965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1.
    Deleruyelle LJ
    Int J Pharm Compd; 2016; 20(5):359-364. PubMed ID: 28339370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy.
    Nachtigall MJ; Smilen SW; Nachtigall RD; Nachtigall RH; Nachtigall LE
    Obstet Gynecol; 1992 Nov; 80(5):827-30. PubMed ID: 1328978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.